PRIOR-M: Predicting treatment Response In spOndyloarthRitis using gut Microbiome
Ondersteund project van Dirk Elewaut en Emilie Dumas : The gut-joint axis is a key concept in our current understanding of spondyloarthritis. Considering the emerging role of gut dysbiosis in its pathogenesis, this project will investigate the predictive value of gut microbial alterations and gut barrier integrity markers for assessment of treatment outcomes in axial SpA patients (i.e. responders versus non-responders). Microbiome-based predictive tools will allow informed clinical decision-making and pave the way towards personalized medicine.
Kregen ook steun
KU Leuven (RA Clinical Research Group, Skeletal Biology and Engineering Research Centre, Department of Development and Regeneration, KU Leuven)
What is the optimal tapering strategy for rituximab in patients with Rheumatoid Arthritis: comparison of interval prolongation with disease activity guided dose reduction
Ondersteund project van Patrick Verschueren : Rituximab is an effective drug, but it is expensive and might be accompanied by an increased infection risk. Therefore, lowering the…
Anti-UH-RA antibody reactivity for prediction of response to first-line therapy in rheumatoid arthritis: validation in the independent CAP48 cohort
Ondersteund project van Patrick Van Dormael : Recently, baseline antibodies against 3 University Hasselt (UH)-RA antigens were found to be predictive for failure to achieve respo…
The prevalence of spondyloarthritis-like structural lesions of the sacroiliac joints on MRI in postpartum women.
Ondersteund project of Filip Van den Bosch : A former study in 35 healthy postpartum women showed prevalence of sacroiliac bone marrow edema (BME) on magnetic resonance (MRI), re…